Lenz Therapeutics Inc (LENZ)

Mar 11, 2025

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025 - The Manila Times

Mar 11, 2025

Mar 11, 2025

LENZ Therapeutics Q4 Earnings: Key Updates Coming on Presbyopia Eye Drops - StockTitan

Mar 11, 2025

Mar 09, 2025

Rhumbline Advisers Boosts Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Mar 09, 2025

Mar 03, 2025

LENZ Therapeutics to Host Commercial Day on April 15, 2025 - The Manila Times

Mar 03, 2025

Mar 03, 2025

Will LENZ's Presbyopia Eye Drop Disrupt the Vision Care Market? Commercial Strategy Reveal Coming - StockTitan

Mar 03, 2025

Feb 25, 2025

Insiders Enjoy US$227k Return After Buying LENZ Therapeutics Stock - Simply Wall St

Feb 25, 2025

Feb 24, 2025

LENZ Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Feb 24, 2025

Feb 24, 2025

LENZ Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Nasdaq

Feb 24, 2025

Feb 24, 2025

Can LENZ's Novel Presbyopia Treatment Disrupt the $8B Eye Care Market? Key Investor Presentations Coming - StockTitan

Feb 24, 2025

Feb 23, 2025

Myopia And Presbyopia Eye Drops Market Future Business - openPR

Feb 23, 2025

Feb 21, 2025

LENZ Therapeutics (LENZ) to Release Quarterly Earnings on Wednesday - Defense World

Feb 21, 2025

Feb 19, 2025

LENZ Therapeutics Insiders Placed Bullish Bets Worth US$551.1k - Yahoo Finance UK

Feb 19, 2025

Feb 18, 2025

Citi maintains Buy on LENZ Therapeutics, target at $44 By Investing.com - Investing.com Canada

Feb 18, 2025

Feb 18, 2025

Citi maintains Buy on LENZ Therapeutics, target at $44 - Investing.com

Feb 18, 2025

Feb 16, 2025

Mirae Asset Global Investments Co. Ltd. Makes New Investment in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Feb 16, 2025

Feb 16, 2025

916 Shares in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Acquired by Mirae Asset Global Investments Co. Ltd. - Defense World

Feb 16, 2025

Feb 13, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Down 4.7%Should You Sell? - MarketBeat

Feb 13, 2025

Feb 10, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Acquired by SG Americas Securities LLC - Defense World

Feb 10, 2025

Feb 07, 2025

The Presbyopia Market Size to Reach USD 2,513.0 Million by 2035, Impelled by Technological Advancements in Diagnostic Tools - BioSpace

Feb 07, 2025

Feb 07, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Feb 07, 2025

Feb 06, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives $35.40 Average Target Price from Brokerages - Defense World

Feb 06, 2025

Feb 04, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading 8% HigherWhat's Next? - MarketBeat

Feb 04, 2025

Feb 03, 2025

Research Analysts Set Expectations for LENZ FY2025 Earnings - MarketBeat

Feb 03, 2025

Feb 02, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5.1%What's Next? - MarketBeat

Feb 02, 2025

Feb 01, 2025

LENZ Therapeutics (LENZ) to Release Earnings on Wednesday - MarketBeat

Feb 01, 2025

Feb 01, 2025

Leerink Partnrs Has Pessimistic View of LENZ FY2025 Earnings - Defense World

Feb 01, 2025

Jan 31, 2025

More Heart, Less Skin: US FDA’s 2025 Novel Approvals Should Reflect Pipeline Shifts - News & Insights

Jan 31, 2025

Jan 30, 2025

Yankuang Energy Group Company Limited (OTCMKTS:YZCAY) Sees Large Decrease in Short Interest - Defense World

Jan 30, 2025

Jan 29, 2025

Myopia Pipeline 2024: Detailed Clinical Trials - openPR

Jan 29, 2025

Jan 29, 2025

LENZ Therapeutics (LENZ) Expected to Announce Earnings on Wednesday - Defense World

Jan 29, 2025

Jan 25, 2025

Barclays PLC Sells 1,835 Shares of Grupo Financiero Galicia S.A. (NASDAQ:GGAL) - Defense World

Jan 25, 2025

Jan 23, 2025

Presbyopia Market on Track for Major Expansion by 2034, According to DelveInsight - EIN News

Jan 23, 2025

Jan 20, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Sees Significant Increase in Short Interest - Defense World

Jan 20, 2025

Jan 20, 2025

Lincoln Electric Holdings, Inc. (NASDAQ:LECO) Short Interest Down 5.0% in December - Defense World

Jan 20, 2025

Jan 20, 2025

LifeVantage Co. (NASDAQ:LFVN) Short Interest Down 5.4% in December - Defense World

Jan 20, 2025

Jan 20, 2025

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World

Jan 20, 2025

Jan 20, 2025

Morgan Stanley Cuts U.S. Bancorp (NYSE:USB) Price Target to $59.00 - Defense World

Jan 20, 2025

Jan 19, 2025

Short Interest in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Expands By 11.9% - MarketBeat

Jan 19, 2025

Jan 19, 2025

Barclays PLC Has $391,000 Stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Jan 19, 2025

Jan 19, 2025

Barclays PLC Buys 12,051 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Jan 19, 2025

Jan 17, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5%Time to Sell? - MarketBeat

Jan 17, 2025

Jan 14, 2025

Trio-Tech International (NYSE:TRT) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 14, 2025

Jan 13, 2025

Harbor Capital Advisors Inc. Buys Shares of 43,989 LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Jan 13, 2025

Jan 12, 2025

Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $35.40 - Defense World

Jan 12, 2025

Jan 11, 2025

Jane Street Group LLC Acquires Shares of 12,027 LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Jan 11, 2025

Jan 10, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Down 8.9%Here's What Happened - MarketBeat

Jan 10, 2025

Jan 10, 2025

Intellia stock hurts gene editing after layoffs (NTLA:NASDAQ) - Seeking Alpha

Jan 10, 2025